Management Team

Stephane crop

Stéphane Bédard, President, CEO and Chairman of the Board

Stéphane has more than 15 years of experience in the creation and management of high-tech companies. Former COO of Victhom Human Bionics Inc. (TSX:VHB), a medical device company that he founded in 1998, Mr. Bédard is recognized within the orthotic and prosthetic community as the inventor of the Power Knee™, the first motorized leg prosthesis for above-knee (AK) amputees.

Read more »

The Power Knee™ is seen as the new generation of AK prosthesis and has dramatically changed the way to design, to fit and to use a leg prosthesis.  Highlights from Stéphane resume are summarized below:

  • Founder of Victhom Human Bionics Inc.;
  • Inventor of the Power Knee™, the first motorized bionic leg prosthesis for AK amputees;
  • Chief Operating Officer of Victhom Human Bionics Inc.;
  • Over 15 years of experience as a senior manager (Maxivox Inc. and Victhom Inc.);
  • Electrical engineer, Masters in mechanical engineering and Doctoral studies in biomechatronics;
  • Author or co-author of approximately 90 patents in the field of biomechatronics and exercisers;
  • Strong scientific background in the field of robotics, automation and biomechatronics;
  • Principal investigator of numerous clinical trials for Class II medical devices;
  • Speaker at numerous international conferences and symposiums.
Pamela Borges

Pamela Borges, VP Market Access and External Affairs

Pamela is a market access, external affairs and communications strategist who has worked in the biopharmaceutical and medical device industry both in Canada and internationally for over 19 years.

Read more »

She has commercialized products across a broad range of therapeutic areas, including those in chronic and rare disorder categories. As a Canadian and global brand manager for Plavix®, she drove the global market development strategy, branding, and value story communication plan for the Top 6 markets, EU, Intercontinental and Asia Pacific regions. With the evolution of government and private sector regulatory changes in reimbursement, she has held leadership roles in multiple organizations to elevate the priority of patient access and the development of an integrated strategic approach with stakeholder engagement, health economics, real world data, pricing and contracting. Pamela has served as Chair of the Market Access Working Group at BIOTECanada and Co-Chair of Joint HTA Committee at Innovative Medicines Canada to lead industry efforts to advocate for efficient, consistent health technology assessment and pricing policies to support the value of the innovation for patients and society. In her various positions, she has been based in Toronto, Montreal and Paris. She holds a Bachelor of Science from the University of Toronto.

Daniel Rivard

Daniel Rivard, Director Manufacturing

Daniel has worked in the medical device and pharmaceutical sectors for the past 20 years, first as production director than as general manager for STERIS Canada Corporation, word leader in washing, decomtamination and sterilization equipment.

Read more »

During these years, production capacity was more than doubled throught the introduction of lean principles and the construction of a state of art plant. He then joined Orthofab, designer of powered wheelchairs and devices for mobility impaired customers as vice president market development leading the diversification of the business. Back in the pharmaceutical manufacturing environment with GlaxoSmithKline as technical services director, leading the expansion of plant capacity with two new filling lines. He was also responsible for risk management process and business continuity plan. He then joined TSO3, an innovator in sterilization of endoscope to lead the introduction in production of the new FDA approved sterilizer. He now has a consulting firms helping businesses increase productivity, profitability, review cost structures, deploy quality systems.Prior to these work experiences, he worked in roles of operations manager, quality manager, engineering supervisor, design engineer with Bombardier, St-Lawrence Cement and Manac. Mechanical Engineer, MBA and Certified Board Administrator.

Keven crop

Keven Beauregard, Director Finance & Administration

Keven joined B-TEMIA in February 2016. He has more than 8 years of experience in administration, finance and leadership roles and have a strong experience in audit and in operational accounting.  Before joining B-TEMIA, he was auditor for multiple public and private companies in a large accounting firm.

Read more »

Keven was also involved in the corporate finance of a public start up listed at the TSX venture in the clean tech industry.  In these roles, Keven discovered a passion for start-up companies.  Highlights from Keven’s resume are summarized below: Production of periodical financials statements and managements reports; Closing of financing for the acquisition of capital assets; Managing the financial forecast model; Establishment of a corporate structure for the growing phase of a start up; Member of the order of Chartered Professional Accountants.

Nori Minicilli

Nori Minicilli, Director of Sales

Nori is pleased for the opportunity to grow with B-TEMIA Inc. since joining the company in April 2017.Coming from a strong healthcare business background and acumen with rigorous experience throughout North America, Nori brings more than eleven years of proven expertise within the medical device industry. Nori genuinely prides himself on guiding and tailoring unique business solutions to meet and exceed the expectations of his clients and team.

Read more »

Prior to his involvement with B-Temia Inc. and this emerging robust industry, Nori managed and grew a multi-million dollars annual book of business within the durable medical equipment industry in the United States for a privately held medical device distributor. Having worked in both the USA and Canada, highlights from Nori’s resume include growing territories within the medical device sector, executing fresh sales initiatives, and solidly defining and implementing comprehensive new business growth strategies.